---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007172"
form_type: "8-K"
ticker: "ANIX"
cik: "0000715446"
company_name: "Anixa Biosciences Inc"
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T06:04:02.978072+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Anixa Biosciences stockholders re-elect four directors, approve say-on-pay, ratify auditor

## Summary
- Re-elected Dr. Amit Kumar (10.26M for, 940k withheld), Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton Jr.
- Non-binding advisory vote on executive compensation passed: 9.17M for, 1.82M against, 221k abstain.
- Ratified Haskell & White LLP as auditor for FY ending Oct 31, 2023: 20.44M for, 61k against.
- Annual meeting held March 9, 2023; 20.97M shares represented out of 30.92M outstanding.

## SEC filing metadata
- accession: 0001493152-23-007172
- form_type: 8-K
- ticker: ANIX
- cik: 0000715446
- company_name: Anixa Biosciences Inc
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007172
- JSON: https://secwatch.observer/filing/0001493152-23-007172.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007172.txt

## Key facts
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Election of directors at the 2023-03-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-03-09
  source text: Proposal No. 1 – Election of directors Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. were each re-elected to serve until the 2024 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 10,263,393 940,600 9,765,865 Dr. Arnold Baskies 10,273,898 930,095 9,765,865 Emily Gottschalk 10,055,355 1,148,638 9,765,865 Lewis H. Titterton, Jr. 9,825,204 1,378,789 9,765,865
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2023-03-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-03-09
  source text: Proposal No. 3 – Ratification of the appointment of independent registered public accounting firm The appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2023 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 20,439,779 61,616 468,463 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Approval, by non-binding advisory vote, of the Company's executive compensation at the 2023-03-09 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-03-09
  source text: Proposal No. 2 – Approval, by non-binding advisory vote, of the Company’s executive compensation The Company’s executive compensation, by non-binding advisory vote, was approved. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 9,166,107 1,816,322 221,564 9,765,865
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.